Association of MASLD severity with subclinical coronary atherosclerosis

This study analyzed 7,507 participants to investigate the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) severity and coronary artery calcification (CAC). MASLD severity was significantly associated with subclinical atherosclerosis, especially in hypertensive individuals. Moderate and severe MASLD correlated with higher CAC stages, independent of traditional cardiovascular disease (CVD) risk factors.